CNVI:CA:TSV-Conavi Medical Corp. (CAD)

COMMON STOCK | Medical Devices |

Last Closing

USD 0.68

Change

-0.07 (-9.33)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-07 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
TLT:CA Theralase Technologies Inc.

-0.01 (-1.64%)

USD 0.07B
PINK:CA Perimeter Medical Imaging AI I..

+0.03 (+6.02%)

USD 0.05B
ASG:CA Aurora Spine Corp

+0.01 (+2.13%)

USD 0.03B
MDX:CA MedX Health Corp

N/A

USD 0.02B
NGMD:CA NuGen Medical Devices Inc

N/A

USD 0.02B
VPT:CA VentriPoint Diagnostics Ltd

+0.01 (+4.76%)

USD 0.02B
THRM:CA Therma Bright Inc

-0.01 (-12.50%)

USD 0.01B
EVMT:CA Evome Medical Technologies Inc..

+0.01 (+3.45%)

USD 0.01B
FREQ:CA Frequency Exchange Corp.

N/A

USD 0.01B

ETFs Containing CNVI:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.62% 10% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.62% 10% F 47% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike